Multiple sclerosis is an inflammatory, demyelinating disease in which antigens of the myelin sheath have been considered the autoimmune target. A recent study suggests that the potassium channel KIR4.1 is another potential autoantigen in some patients with multiple sclerosis, and might also be a target in other demyelinating diseases.
References
Frohman, E. M., Racke, M. K. & Raine, C. S. Multiple sclerosis—the plaque and its pathogenesis. N. Engl. J. Med. 354, 942–955 (2006).
Hauser, S. L. et al. B-cell depletion with rituximab in relapsing–remitting multiple sclerosis. N. Engl. J. Med. 358, 676–688 (2008).
Srivastava, R. et al. Potassium channel KIR4.1 as an immune target in multiple sclerosis. N. Engl. J. Med. 367, 115–123 (2012).
Masaki, H. et al. Immunocytochemical studies of aquaporin 4, Kir4.1, and α1-syntrophin in the astrocyte endfeet of mouse brain capillaries. Acta Histochem. Cytochem. 43, 99–105 (2010).
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S. & Hinson, S. R. IgG marker of optic–spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202, 473–477 (2005).
Roemer, S. F. et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 130, 1194–1205 (2007).
Hinson, S. R. et al. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc. Natl Acad. Sci. USA 109, 1245–1250 (2012).
Scott, T. F. et al. Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 77, 2126–2134 (2011).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
M. K. Racke has consulted for Biogen Idec, Novartis, and Revalesio.
Rights and permissions
About this article
Cite this article
Racke, M. The potassium channel KIR4.1—a potential autoantigen in MS. Nat Rev Neurol 8, 595–596 (2012). https://doi.org/10.1038/nrneurol.2012.193
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2012.193
- Springer Nature Limited